Khan Mohd Aleem, Khan Naeem Ahmad, Qasmi Iqbal Ahmad, Ahmad Ghufran, Zafar Shadab
Department of Ilmul Advia (Pharmacology), Faculty of Unani Medicine, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India.
BMC Complement Altern Med. 2004 Jul 6;4:8. doi: 10.1186/1472-6882-4-8.
Diarrhoea is a major health problem for children worldwide, accounting for 5-8 million deaths each year. Arque-Ajeeb (AA) is a compound formulation of Unani medicine. It is reputed for its beneficial effects in the treatment of diarrhoea and cholera, but the claim of its efficacy is yet to be tested. Therefore the present study has been planned to investigate the real efficacy of this drug in rats.
The effect of Arque-Ajeeb was investigated for antidiarrhoeal activity against charcoal-induced gut transit, serotonin-induced diarrhoea and PGE2-induced small intestine enteropooling in rats. The control, standard and test groups of experimental animals were administered with normal saline (p.o.), diphenoxylate hydrochloride (5 mg/kg, p.o.) and Arque-Ajeeb (0.07 ml and 0.14 ml/kg, p.o.) respectively except the control group of PGE2-induced small intestine enteropooling which received only 5% ethanol in normal saline (i.p.). Charcoal (10 ml/kg, p.o.) and serotonin (600 micrograms/kg, i.p.) were administered after 30 min, while PGE2 (100 micrograms/kg, p.o.) was administered immediately afterwards. The distance traveled by charcoal in small intestine was measured after 15 and 30 min of charcoal administration, diarrhoea was observed every 30-min for six hour after serotonin administration and the volume of intestinal fluid was measured after 30 min of PGE2 administration.
Arque-Ajeeb (0.07 ml and 0.14 ml/kg) significantly inhibited the frequency of defaecation and decreased the propulsion of charcoal meal through the gastrointestinal tract, reduced the wetness of faecal droppings in serotonin-induced diarrhoea and also reduced the PGE2-induced small intestine enteropooling.
Arque-Ajeeb may have potential to reduce the diarrhoea in rats. Thus the drug may prove to be an alternate remedy in diarrhoea.
腹泻是全球儿童面临的一个主要健康问题,每年导致500万至800万人死亡。阿克-阿吉布(AA)是一种尤纳尼医学的复方制剂。它因在治疗腹泻和霍乱方面的有益效果而闻名,但尚未对其疗效宣称进行检验。因此,本研究旨在探究该药物在大鼠体内的实际疗效。
研究了阿克-阿吉布对大鼠木炭诱导的肠道转运、血清素诱导的腹泻以及前列腺素E2诱导的小肠肠液积聚的止泻活性。实验动物的对照组、标准组和测试组分别给予生理盐水(口服)、盐酸地芬诺酯(5毫克/千克,口服)和阿克-阿吉布(0.07毫升/千克和0.14毫升/千克,口服),但前列腺素E2诱导的小肠肠液积聚对照组仅接受生理盐水(腹腔注射)中的5%乙醇。30分钟后给予木炭(10毫升/千克,口服)和血清素(600微克/千克,腹腔注射),随后立即给予前列腺素E2(100微克/千克,口服)。在给予木炭后15分钟和30分钟测量木炭在小肠内移动的距离,在给予血清素后每30分钟观察6小时腹泻情况,并在给予前列腺素E2后30分钟测量肠液体积。
阿克-阿吉布(0.07毫升/千克和0.14毫升/千克)显著抑制排便频率,减少木炭粉在胃肠道的推进,降低血清素诱导腹泻中粪便的湿度,还减少了前列腺素E2诱导的小肠肠液积聚。
阿克-阿吉布可能有减轻大鼠腹泻的潜力。因此,该药物可能被证明是治疗腹泻的替代药物。